SCHEMBL6205796

SCHEMBL6205796

CCCCC1CCCCN(C(N)=O)C1=O

nearest known ligand 0.36

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
ALDH1A1 P00352 1/20 0.35
SPHK1 Q9NYA1 5/20 0.34
SPHK2 Q9NRA0 3/20 0.34
CYP2C9 P11712 1/20 0.34
ELANE P08246 1/20 0.34
BCHE P06276 1/20 0.34
CHRNB2 P17787 1/20 0.34
CHRNA7 P36544 1/20 0.34
CHRNA4 P43681 1/20 0.34
CYP1A2 P05177 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
ACE P12821 1/20 0.32
HTT P42858 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23907338 0.89 NAAA (0.37) ALDH1A1SPHK1CHRNB2CHRNA7CHRNA4
SCHEMBL6204538 0.84 NOS3 (0.39) ALDH1A1ACEHTTSMN1; SMN2
SCHEMBL28055445 0.82 ACE (0.39) MEN1KMT2AALDH1A1ELANEBCHE
SCHEMBL6338204 0.76 ELANE (0.38) MEN1KMT2AALDH1A1CYP2C9ELANE
SCHEMBL27658289 0.76 ACE (0.38) ALDH1A1ELANECHRNB2CHRNA7CHRNA4
SCHEMBL11035603 0.75 FAAH (0.44) MEN1KMT2ACYP2C9ELANEBCHE
SCHEMBL1907356 0.74 CHRNB2 (0.42) ALDH1A1CHRNB2CHRNA7CHRNA4CYP1A2
SCHEMBL6739162 0.73 CHRNB2 (0.44) ALDH1A1CHRNB2CHRNA7CHRNA4CYP1A2
SCHEMBL868861 0.72 ALDH1A1 (0.36) ALDH1A1CHRNB2CHRNA7CHRNA4CYP1A2
SCHEMBL28354841 0.72 GBA1 (0.42) ALDH1A1BCHECHRNB2CHRNA7CHRNA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1534681-A1 SUBSTITUTED QUINOLINE CCR5 RECEPTOR ANTAGONISTS SCHERING AKTIENGESELLSCHAFT (DE) 2005-06-01 EP claimed
WO-2004002960-A1 SUBSTITUTED QUINOLINE CCR5 RECEPTOR ANTAGONISTS SCHERING AKTIENGESELLSCHAFT (DE) 2004-01-08 WO claimed
EP-1534681-A1 SUBSTITUTED QUINOLINE CCR5 RECEPTOR ANTAGONISTS SCHERING AKTIENGESELLSCHAFT (DE) 2005-06-01 EP disclosed
WO-2004002960-A1 SUBSTITUTED QUINOLINE CCR5 RECEPTOR ANTAGONISTS SCHERING AKTIENGESELLSCHAFT (DE) 2004-01-08 WO disclosed